The anti-addictive drug noribogaine was functionally characterized at the opioid receptors.
Noribogaine is a G-protein biased kappa opioid agonist.
Noribogaine is also a mu antagonist and a beta-arrestin biased kappa antagonist.
The unique pharmacological profile of noribogaine may explain its atypical effects on the opioid system in vivo.